CAPPELLARI, Ornella
 Distribuzione geografica
Continente #
NA - Nord America 754
EU - Europa 193
AS - Asia 102
SA - Sud America 3
Totale 1.052
Nazione #
US - Stati Uniti d'America 750
IT - Italia 76
SE - Svezia 68
SG - Singapore 51
CN - Cina 26
GB - Regno Unito 19
VN - Vietnam 15
CZ - Repubblica Ceca 11
DE - Germania 8
HK - Hong Kong 5
BE - Belgio 4
CA - Canada 4
FI - Finlandia 4
BR - Brasile 3
IN - India 2
FR - Francia 1
ID - Indonesia 1
IR - Iran 1
JP - Giappone 1
NL - Olanda 1
RU - Federazione Russa 1
Totale 1.052
Città #
Chandler 143
Fairfield 88
Nyköping 65
Ashburn 42
Cambridge 42
Singapore 37
Houston 35
Woodbridge 34
Seattle 33
Lawrence 25
Wilmington 24
Inglewood 21
Bari 20
Des Moines 20
Roxbury 19
Ann Arbor 17
Dong Ket 15
San Diego 13
New York 12
Brno 11
Santa Clara 10
Taranto 10
London 8
Guangzhou 7
Milan 7
Princeton 6
Hong Kong 5
Brussels 4
Helsinki 4
Modugno 4
Norwalk 4
Albairate 3
Redwood City 3
Barletta 2
Frankfurt am Main 2
Gioia Del Colle 2
Grottaglie 2
Munich 2
Naples 2
New Bedfont 2
Nulvi 2
Ottawa 2
St Helens 2
Toronto 2
Amsterdam 1
Ardabil 1
Bauru 1
Beijing 1
Boardman 1
Brooklyn 1
Capitão Poço 1
Chicago 1
Chiswick 1
Dalian 1
Dearborn 1
Falkenberg 1
Fulham 1
Hounslow 1
Islington 1
Jakarta 1
Jiaxing 1
Kagoya 1
Kilburn 1
Los Angeles 1
Monmouth Junction 1
Mumbai 1
Nanchang 1
Nanjing 1
Padova 1
Paraisópolis 1
Pune 1
San Francisco 1
Sindelfingen 1
Tolmezzo 1
Trento 1
Wuhan 1
Wuxi 1
Totale 846
Nome #
Proof-of-concept validation of the mechanism of action of Src tyrosine kinase inhibitors in dystrophic mdx mouse muscle: in vivo and in vitro studies 107
Musculoskeletal geometry, muscle architecture and functional specialisations of the mouse hindlimb 77
Safety issues and harmful pharmacological interactions of nutritional supplements in Duchenne muscular dystrophy: considerations for Standard of Care and emerging virus outbreaks 65
Cisplatin-Induced Skeletal Muscle Dysfunction: Mechanisms and Counteracting Therapeutic Strategies 62
Ergogenic effect of bcaas and l-alanine supplementation: Proof-of-concept study in a murine model of physiological exercise 59
A dynamic simulation of musculoskeletal function in the mouse hindlimb during trotting locomotion 48
Functional Rescue of Dystrophin Deficiency in Mice Caused by Frameshift Mutations Using Campylobacter jejuni Cas9 48
Gain-of-Function STIM1 L96V Mutation Causes Myogenesis Alteration in Muscle Cells From a Patient Affected by Tubular Aggregate Myopathy 46
Muscle moment arms and sensitivity analysis of a mouse hindlimb musculoskeletal model 43
Inhibition of myostatin improves muscle atrophy in oculopharyngeal muscular dystrophy (OPMD) 42
Noggin recruits mesoderm progenitors from the dorsal aorta to a skeletal myogenic fate 40
Established PABPN1 intranuclear inclusions in OPMD muscle can be efficiently reversed by AAV-mediated knockdown and replacement of mutant expanded PABPN1 40
Ultrasonography validation for early alteration of diaphragm echodensity and function in the mdx mouse model of Duchenne muscular dystrophy 40
Pharmacological modulation of the ER stress response ameliorates oculopharyngeal muscular dystrophy 39
"The Social Network" and Muscular Dystrophies: The Lesson Learnt about the Niche Environment as a Target for Therapeutic Strategies 38
BCAAs and Di-Alanine supplementation in the prevention of skeletal muscle atrophy: preclinical evaluation in a murine model of hind limb unloading 38
β‐Dystroglycan Restoration and Pathology Progression in the Dystrophic mdx Mouse: Outcome and Implication of a Clinically Oriented Study with a Novel Oral Dasatinib Formulation 37
Dll4 and PDGF-BB Convert Committed Skeletal Myoblasts to Pericytes without Erasing Their Myogenic Memory 35
Three-Dimensional Human iPSC-Derived Artificial Skeletal Muscles Model Muscular Dystrophies and Enable Multilineage Tissue Engineering 34
Pericytes in development and pathology of skeletal muscle 34
Simvastatin Treatment Does Not Ameliorate Muscle Pathophysiology in a Mouse Model for Duchenne Muscular Dystrophy 28
Circadian Genes as Exploratory Biomarkers in DMD: Results From Both the mdx Mouse Model and Patients 28
Transplantation of genetically corrected human iPSC-derived progenitors in mice with limb-girdle muscular dystrophy 26
BB-301: a silence and replace AAV-based vector for the treatment of oculopharyngeal muscular dystrophy 19
A versatile system for neuromuscular stimulation and recording in the mouse model using a lightweight magnetically coupled headmount 17
Branched-Chain Amino Acids and Di-Alanine Supplementation in Aged Mice: A Translational Study on Sarcopenia 15
Growth hormone secretagogues modulate inflammation and fibrosis in mdx mouse model of Duchenne muscular dystrophy 13
LKB1 signaling is altered in skeletal muscle of a Duchenne muscular dystrophy mouse model 13
Ion channels as biomarkers of altered myogenesis in myofiber precursors of Duchenne muscular dystrophy 6
Dll4 and PDGF-BB Convert Committed Skeletal Myoblasts to Pericytes without Erasing Their Myogenic Memory 2
Totale 1.139
Categoria #
all - tutte 8.995
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.995


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202033 0 0 0 0 5 3 6 6 4 6 1 2
2020/2021325 6 5 0 130 42 3 1 36 23 42 18 19
2021/2022185 30 2 3 0 1 18 13 6 9 15 43 45
2022/2023339 29 46 30 25 40 47 9 35 49 4 11 14
2023/2024144 11 36 7 10 10 18 2 6 4 9 5 26
2024/2025103 24 2 44 18 15 0 0 0 0 0 0 0
Totale 1.139